The efficacy and tolerability of quetiapine versus divalproex for the treatment of impulsivity and reactive aggression in adolescents with co-occurring bipolar disorder and disruptive behavior disorder(s)

Journal of Child and Adolescent Psychopharmacology

Volumn 16, Issue 6, 2006, Pages 665-670

  Barzman, Drew H ^a,b   DelBello, Melissa P ^a,b   Adler, Caleb M ^c   Stanford, Kevin E ^a   Strakowski, Stephen M ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c Cincinnati Children's Hospital Medical Center ^*

Author keywords

[No Author keywords available]

Indexed keywords

QUETIAPINE; VALPROATE SEMISODIUM;

ADOLESCENT; AGGRESSION; ANALYSIS OF VARIANCE; ARTICLE; BIPOLAR DISORDER; BIPOLAR I DISORDER; CLINICAL ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISRUPTIVE BEHAVIOR; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; IMPULSIVENESS; MALE; MANIA; MONOTHERAPY; OPPOSITIONAL DEFIANT DISORDER; OUTCOME ASSESSMENT; POSITIVE AND NEGATIVE SYNDROME SCALE; POST HOC ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEDATION; SIDE EFFECT; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 33846648442     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2006.16.665     Document Type: Article

References (13)

1. Biederman J, Mick E, Faraone SV, Spencer T, Wilens RE, Wozniak J: Pediatric mania: A developmental subtype of bipolar disorder? Biol Psychiatry 48:458-466, 2000.
2. DelBello MP, Adler C, Strakowski SM: Divalproex for the treatment of agitation associated with adolescent mania. J Child Adolesc Psychopharmacol 14:325-328, 2004.
3. DelBello, MP, Kowatch RA, Adler CM, Stanford KE, Welge JA, Barzman DH, Nelson E, Strakowski SM: A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania. J Am Acad Child Adolesc Psychiatry 45:305-313, 2006.
4. Donovan SJ, Susser ES, Nunes EV, Stewart JW, Quitkin FM, Klein DF: Divalproex treatment of disruptive adolescents: A report of 10 cases. J Clin Psychiatry 58:12-15, 1997.
5. Donovan SJ, Stewart JW, Nunes EV, Quitkin FM, Parides M, Daniel W, Susser E, Klein DF: Divalproex treatment for youth with explosive temper and mood lability: A double-blind, placebo-controlled crossover design. Am J Psychiatry 157:818-820, 2000.
6. Findling RL, McNamara NK, Branicky LA, Scluchter MD, Lemon E, Blumer JL: A double-blind pilot study of risperidone in the treatment of conduct disorder. J AM Acad Child Adolesc Psychiatry 39:509-516, 2000.
7. Geller B, Williams M, Zimerman B, Frazier J, Beringer L, Warner KL: Prepubertal and early adolescent bipolarity differentiate from ADHD by manic symptoms, grandiose delusions, ultra-rapid or ulradian cycling. J Affect Disord 51:81-91, 1998.
8. King B, Zwi K, Nunn k, Longworth J, Dossetor D: Use of risperidone in a pediatric population: An observational study. J Paediatric Child Health 39:523-527, 2003.
9. Soderstrom H, Rastam M, Gillberg C: A clinical case series of six extremely aggressive youths treated with olanzapine. Eur Child Adolesc Psychiatry 11:138-141, 2002.
10. Staller JA: Intramuscular ziprasidone in youth: A retrospective chart review. J Child Adolesc Psychopharmacol 14:590-592, 2004.
11. West SA, McElroy SL, Strakowski SM, Keck PE, McConville BJ: Attention-deficit hyperactivity disorder in adolescent mania. Am J Psychiatry 152:271-273, 1995.
12. Wozniak J, Biederman J, Kiely K, Ablon S, Faraone S, Mundy E, Menin D: Mania-like symptoms suggestive of childhood onset bipolar disorder in clinically referred children. J Am Acad Child Adolesc Psychiatry 34:867-876, 1995.
13. Wright P, Meehan K, Birkett M, Lindborg SR, Taylor CC, Morris P, Breier A: A comparison of the efficacy and safety of olanzapine versus haloperidol during transition from intramuscular to oral therapy. Clin Ther. 5:1420-1428, 2003.